Impact of a Peer-Delivered Telephone Intervention for Women Experiencing a Breast Cancer Recurrence
Year: 2007
Type: article
Study design: Clinical Trial
Abstract: PURPOSE: A first breast cancer recurrence creates considerable distress, yet few psychosocial interventions directed at this population have been reported. The Southwest Oncology Group conducted a phase III randomized trial to evaluate the effectiveness of a brief telephone intervention. PATIENTS AND METHODS: Three hundred five women experiencing a first recurrence of breast cancer were randomly assigned to standard care or intervention. The intervention consisted of four to eight telephone calls delivered over a 1-month period. The calls were conducted by trained peer counselors at a breast cancer advocacy organization, the Y-ME National Breast Cancer Organization, and followed a standard curriculum. Psychosocial distress (Cancer Rehabilitation Evaluation System-Short Form [CARES-SF]) and depressive symptoms (Center for Epidemiologic Studies Depression Scale [CES-D]) outcomes were assessed at baseline and 3 and 6 months. The 3-month assessment was the primary end point and is the focus of this article. RESULTS: Analysis revealed no differences in distress or depressive symptoms at 3 months between the intervention and control groups; at 3 months, 70% of control patients and 66% of intervention patients reported psychosocial distress, and 40% of control patients and 47% of intervention patients exhibited depressive symptoms. CONCLUSION: Telephone peer counseling did not lead to better psychosocial outcomes. The persistent distress in these women supports the urgent need for the development and testing of more intensive or different supportive interventions for this group of patients.
Source: Journal of Clinical Oncology
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: SOUTHWEST ONCOLOGY GROUP, G1033243903, Southwest Oncology Group, Greenville SC CCOP, G117886320, G1268312386, G1331445602, G1375689152, Columbus Community Clinical Oncology Program (Columbus CCOP), G1469275664, G1646027999, COOPERATIVE STUDY OF CANCER CHEMOTHERAPY, UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP, G1790576020, G1911575068, G1958973285, G20028727, G2064543036, Scott & White Community Clinical Oncology Program, G2160369479, G2397742718, G2419449687, G2562936776, G268786457, WESTERN ONCOLOGY RESEARCH CONSORTIUM, G2745671310, COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM, Southwest Oncology Group, Southwest Oncology Group U10 Member Site, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3108454457, G3126600779, G313314762, G3350348941, G345775953, G413878341, Southwest Oncology Group, Dayton Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS, G425646771, Southwest Oncology Group, New Mexico Minority Based Community Clinical Oncology Program, G4527800867, SOUTHWEST ONCOLOGY GROUP, G4719029039, G4935167430, G5125348268, G5415431867, G5504618518, SOUTHWEST ONCOLOGY GROUP CA13612, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group, Gulf Coast MBCCOP, Atlanta Regional Community Clinical Oncology Program (ARCCOP), SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, G6943608702, G7061256793, NORTHWEST COMMUNITY CLINICAL ONCOLOGY PROGRAM, G712978930, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, Hawaii Minority-Based Clinical Community Oncology Program, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, Virginia Mason Community Clinical Oncology Program, G763325562, G791413246, G8116866424, Beaumont Community Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP, G933283670, G937543590, G960417071, G971274320, Southwest Oncology Group/University of California, Davis
OpenAlex ID: W2138698086